{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/prov/438638910"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/221909193" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/436841055"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/221909193" ] } },

    { "id" : "http://webisa.webdatacommons.org/221909193"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Type I diabetes, hypertriglyceridemia. syndrome X, insulin resistance, heart failure, diabetic dyslipidemia, hyperlipidemia. hypercholesteremia, hypertension, obesity, anorexia bulimia, anorexia nervosa, cardiovascular disease and other diseases where insulin resistance is a component, comprising the step of administering an effective amount of at least one compound of Claims 1-24." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.it" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/340785538"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/221909193" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/436104151"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/221909193" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/435237623"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/221909193" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/219000075"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/221909193"] } } }
